These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26481548)

  • 1. Antidiabetic drugs and risk of cancer.
    Tokajuk A; Krzyżanowska-Grycel E; Tokajuk A; Grycel S; Sadowska A; Car H
    Pharmacol Rep; 2015 Dec; 67(6):1240-50. PubMed ID: 26481548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperglycaemic therapies and cancer risk.
    Lutz SZ; Staiger H; Fritsche A; Häring HU
    Diab Vasc Dis Res; 2014 Nov; 11(6):371-89. PubMed ID: 25231191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
    Panicker GK; Karnad DR; Salvi V; Kothari S
    J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we have enough data to confirm the link between antidiabetic drug use and cancer development?
    Drzewoski J; Drozdowska A; Sliwińska A
    Pol Arch Med Wewn; 2011 Mar; 121(3):81-7. PubMed ID: 21430609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Diabetic Drugs: Cure or Risk Factors for Cancer?
    Laskar J; Bhattacharjee K; Sengupta M; Choudhury Y
    Pathol Oncol Res; 2018 Oct; 24(4):745-755. PubMed ID: 29536373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
    Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.
    Tuccori M; Convertino I; Galiulo MT; Marino A; Capogrosso-Sansone A; Blandizzi C
    Expert Opin Drug Saf; 2017 Oct; 16(10):1133-1148. PubMed ID: 28748718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.
    Shlomai G; Neel B; LeRoith D; Gallagher EJ
    J Clin Oncol; 2016 Dec; 34(35):4261-4269. PubMed ID: 27903154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review.
    Derosa G; Maffioli P
    Clin Ther; 2012 Jun; 34(6):1221-36. PubMed ID: 22560622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes and cancer risk: oncologic considerations].
    Rosta A
    Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan.
    Naser AY; Wong ICK; Whittlesea C; Beykloo MY; Man KKC; Lau WCY; Hyassat DA; Wei L
    BMJ Open; 2018 Nov; 8(11):e024909. PubMed ID: 30467136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes.
    Pratley RE; Salsali A
    Curr Med Res Opin; 2007 Apr; 23(4):919-31. PubMed ID: 17407649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into antidiabetic drugs: Possible applications in cancer treatment.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Zarghami N
    Chem Biol Drug Des; 2017 Dec; 90(6):1056-1066. PubMed ID: 28456998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship of antidiabetic drugs and cancer risk].
    Gu YJ; Jia WP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1170-3. PubMed ID: 22336559
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidiabetic Drugs as Antihypertensives: New Data on the Horizon.
    Mamakou V; Eleftheriadou I; Katsiki N; Makrilakis K; Tsioufis K; Tentolouris N
    Curr Vasc Pharmacol; 2017; 16(1):70-78. PubMed ID: 29032756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.
    Lacroix IM; Li-Chan EC
    Mol Nutr Food Res; 2014 Jan; 58(1):61-78. PubMed ID: 23943383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does long-term use of antidiabetic drugs changes cancer risk?
    Liu YC; Nguyen PA; Humayun A; Chien SC; Yang HC; Asdary RN; Syed-Abdul S; Hsu MH; Moldovan M; Yen Y; Li YJ; Jian WS; Iqbal U
    Medicine (Baltimore); 2019 Oct; 98(40):e17461. PubMed ID: 31577776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.